CYTEK BIOSCIENCES, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $405.4M | $364.6M |
| FY2022 | — | $425.5M | $296.6M |
| FY2023 | — | $393.1M | $167.3M |
| FY2024 | — | $395.7M | $98.7M |
| FY2025 | — | $341.7M | $90.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $405.4M | $364.6M |
| FY2022 | — | $425.5M | $296.6M |
| FY2023 | — | $393.1M | $167.3M |
| FY2024 | — | $395.7M | $98.7M |
| FY2025 | — | $341.7M | $90.9M |